Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Emergent Biosolutions Inc. (EBS) vs Alpha Teknova, Inc. (TKNO)

Emergent Biosolutions Inc. and Alpha Teknova, Inc. are both Drug Manufacturers Specialty & Generic companies. Alpha Teknova, Inc. is the larger, with a market value of $498.8M against $347.1M — 1.4× the size. Alpha Teknova, Inc. grew revenue faster over the last twelve months: 12.3% against −9.56%. Emergent Biosolutions Inc. has the higher net margin (−23.0% vs −38.4%) and the higher return on invested capital (−5.27% vs −16.9%). Across the 19 metrics below, Emergent Biosolutions Inc. leads on 12 and Alpha Teknova, Inc. on 7.

Valuation

Metric EBS TKNO Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.14
P/S 0.45 11.45 2.25
P/B 1.03 7.99 1.90
Price to free cash flow 4.07 n/m 16.54
EV/EBITDA 21.47 n/m 12.29
EV/Sales 1.03 11.45 2.56
Earnings yield (50.66%) (3.32%) (2.99%)
Free cash flow yield 24.57% (1.47%) 0.00%

Profitability

Metric EBS TKNO Drug Manufacturers Specialty & Generic median
Gross margin 55.87% 34.60% 53.94%
Operating margin (8.57%) (36.19%) 0.00%
Net margin (22.96%) (38.37%) 0.00%
Free cash flow margin 11.18% (16.83%) 0.00%
Return on equity (40.29%) (24.19%) (0.40%)
Return on assets (13.95%) (16.25%) (3.32%)
Return on invested capital (5.27%) (16.93%) 0.00%

Growth

Metric EBS TKNO Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) (9.56%) 12.27% 10.01%
EPS growth (last fiscal year) 125.83% 43.86% —
Revenue growth, 5-year CAGR (13.74%) 5.30% 6.74%
Net income growth, 5-year CAGR (29.64%) 0.00% 0.00%

Health

Metric EBS TKNO Drug Manufacturers Specialty & Generic median
Debt to equity 1.70 0.21 0.05
Current ratio 5.42 4.49 2.31
Net debt to EBITDA 1.76 0.75 0.85

Dividend

Metric EBS TKNO Drug Manufacturers Specialty & Generic median
Dividend yield 0.79% — 1.70%
Payout ratio 0.00 0.00 0.00

Size

Metric EBS TKNO Drug Manufacturers Specialty & Generic median
Market cap 347.12m 498.76m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack